These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24816356)

  • 1. Characteristics of online pharmacy users in a nationally representative sample.
    Brown J; Li C
    J Am Pharm Assoc (2003); 2014; 54(3):289-94. PubMed ID: 24816356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs.
    Daniel GW; Malone DC
    J Manag Care Pharm; 2007 Mar; 13(2):142-54. PubMed ID: 17330975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and predictors of utilization of community pharmacy generic drug discount programs.
    Gatwood J; Tungol A; Truong C; Kucukarslan SN; Erickson SR
    J Manag Care Pharm; 2011; 17(6):449-55. PubMed ID: 21787030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with prescription drug expenditures among children: an analysis of the Medical Expenditure Panel survey.
    Chen AY; Chang RK
    Pediatrics; 2002 May; 109(5):728-32. PubMed ID: 11986428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of use and expenses associated with mail-service pharmacy in adults with diabetes.
    Wu J; Davis-Ajami ML; Noxon V
    J Am Pharm Assoc (2003); 2015; 55(1):41-51. PubMed ID: 25539092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Per-Prescription Drug Expenditure by Source of Payment and Income Level in the United States, 1997 to 2015.
    Tang W; Xie J; Kong F; Malone DC
    Value Health; 2019 Aug; 22(8):871-877. PubMed ID: 31426927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.
    Hanley GE; Morgan S
    Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in prescription drug insurance coverage.
    Millar WJ
    Health Rep; 1999; 10(4):11-31(ENG); 9-30(FRE). PubMed ID: 10607410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013.
    McPherson T; Fontane P; Iyengar R; Henderson R
    J Manag Care Spec Pharm; 2016 Feb; 22(2):172-81. PubMed ID: 27015256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of an Online Cash-Pay Pharmacy for Topical 5-Fluorouracil Prescriptions in Older Patients.
    Payne JE; Ghamrawi RI; Lin IJ; Feldman SR
    J Drugs Dermatol; 2020 May; 19(5):539-542. PubMed ID: 32484613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an expenditure cap on low-income seniors' drug use and spending in a state pharmacy assistance program.
    Bishop CE; Ryan AM; Gilden DM; Kubisiak J; Thomas CP
    Health Serv Res; 2009 Jun; 44(3):1010-28. PubMed ID: 19291168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of insurance status on access to care and out-of-pocket costs for U.S. individuals with epilepsy.
    Halpern MT; Renaud JM; Vickrey BG
    Epilepsy Behav; 2011 Nov; 22(3):483-9. PubMed ID: 21890417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of health insurance coverage in women's access to prescription medicines.
    Ranji UR; Wyn R; Salganicoff A; Yu H
    Womens Health Issues; 2007; 17(6):360-6. PubMed ID: 18042485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug insurance instability and its correlates: results from the 2000 Medical Expenditure Panel Survey.
    Gupta K; Cline RR; Schondelmeyer SW
    Res Social Adm Pharm; 2006 Jun; 2(2):232-53. PubMed ID: 17138510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.
    Kennedy J; Morgan S
    Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.